| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.074 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |